About Us – Ellele Health

We are exploring innovative approaches to detect and manage gynaecological disease, based on a novel biospecimen collected from the vaginal wall by the Ellele Device. Together with our advanced proprietary downstream analysis, this has presented the opportunity to explore and improve all aspects of gynaecological health.

Despite the crucial role diagnostics play in gynaecological health, particularly in cancer detection, current procedures are archaic, invasive, and lack accessibility. The Ellele Device is minimally invasive, easy to administer, and is far more comfortable for women.

As a partner of Origin Sciences, we are leveraging their proven scientific expertise in cancer diagnostics to rapidly advance solutions for gynaecological conditions.

History

Our parent company, Origin Sciences, developed a medical device for sampling mucosal material that has exfoliated and migrated along the entire colon to the rectum. Diagnostic development has shown promising results by detecting colorectal disease in rectal mucus by utilising genetic, epigenetic, and microbial analysis. The diagnostic approach, integrating multiomic analysis, boasts a predicted sensitivity of 97% and specificity of 95% for colorectal cancer and advanced adenomas.

Building on Origin’s success, Ellele Health has embarked on exploring the applicability of the same technology to a vaginal sample. We began by adapting the existing device to conduct a small-scale feasibility study within the UK. Results indicated very high patient acceptance rates compared to traditional speculum examination, alongside the detection of ample DNA for downstream analysis.

Ellele Health is currently fully funded by Origin Sciences.

We are a women-led medical research company dedicated to transforming diagnostics in women’s health

History

Investors